Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SwedenBack to Sweden

Clinical trials in Stockholm – page 27

745 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Stockholm at a glance
745
clinical trials
  • Research sites8
Type of trial
Recruitment status
Quick filters

745 trials in Stockholm

Open in trial search

Malignant lymphoid neoplasm

Recruiting

Long-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BMS-986515
  • Sponsor:Celgene Corp.

Migraine+2

Recruiting

Study on Long-term Safety and Tolerability of Atogepant for Children and Teens (Ages 6-17) with Migraine

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Medulloblastoma

Recruiting

Study on the Effectiveness of Bevacizumab and Drug Combination for Children with Recurrent or Progressive Medulloblastoma, Ependymoma, and ATRT

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Bevacizumab
  • Sponsor:Medical University Of Vienna

Multiple sclerosis

Recruiting

Comparison of ocrelizumab and rituximab treatment in adults with active relapsing-remitting multiple sclerosis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Helse Bergen HF

Malignant melanoma

Recruiting

Study on Short vs. Long Immunotherapy with Pembrolizumab and Nivolumab for Patients with High-Risk Skin Melanoma After Surgery

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Nivolumab
  • Sponsor:North Estonia Medical Centre Foundation

Brain stem glioma

Recruiting

Study on ONC201 and Everolimus with Radiotherapy for Newly Diagnosed Diffuse Intrinsic Pontine Glioma and Other Diffuse Midline Gliomas in Children, Adolescents, and Adults

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dordaviprone
  • Sponsor:Institut Gustave Roussy

Acute lymphocytic leukaemia

Recruiting

Study on Tioguanine and Drug Combination for Patients Aged 0-45 with Newly Diagnosed Acute Lymphoblastic Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Substances:Blinatumomab
  • Sponsor:Karolinska University Hospital

Neuroendocrine tumour

Recruiting

Study on Personalized vs Non-Personalized Radionuclide Therapy with 177Lu-Edotreotide and Capecitabine for Patients with Neuroendocrine Tumors

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Region Skane

Liver transplant

Recruiting

Study of Donor Specific Immunomodulatory Cells (DSIMC) for Patients with End-Stage Liver Disease Undergoing Liver Transplantation

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Karolinska University Hospital

Alcoholic liver disease

Recruiting

Study on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Glaxosmithkline Research & Development Limited

Neoplasm

Recruiting

Study on Long-Term Safety of BI 907828 for Patients with Solid Tumors Who Previously Participated in a Study with This Medicine

InvestigationalNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Sponsor:Boehringer Ingelheim Espana S.A.

Depression

Recruiting

Study on Adding OSU6162 to Treatment for Patients with Depression Resistant to SSRI/SNRI Medications

Investigational
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:University Of Gothenburg

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Stockholm

What the registry says about research in the country

01 Oncology Research

Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.

  • Prostate Cancer Therapies
  • Breast Cancer Treatments
  • Colorectal Cancer Studies

Innovative research comparing various treatment protocols and investigating survival outcomes.

02 Infectious Diseases

Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.

  • Vaccine Development
  • Viral Disease Prevention
  • Immunization Studies

Focus on prevention and immune response in various age groups.

03 Cardiovascular Health

Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.

  • Cardiac Arrest Management
  • Heart Failure Prevention
  • Cardiomyopathy Treatment

Emphasis on improving patient outcomes and testing novel drug combinations.

04 Neurological Disorders

Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.

  • Disease Modification
  • Symptom Management
  • Treatment Efficacy

Studies evaluating both novel and existing therapeutic approaches.

05 Metabolic Conditions

Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.

  • Weight Management
  • Diabetes Control
  • Metabolic Health

Focus on lifestyle interventions combined with pharmaceutical approaches.

Back to SwedenAll countries
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.